Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival.

Mathé EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, Altorki NK, Casson AG, Liu CG, Wang XW, Yanaihara N, Hagiwara N, Dannenberg AJ, Miyashita M, Croce CM, Harris CC.

Clin Cancer Res. 2009 Oct 1;15(19):6192-200. doi: 10.1158/1078-0432.CCR-09-1467. Epub 2009 Sep 29.

2.

MicroRNA expression profiles of esophageal cancer.

Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, Swanson SJ, Godfrey TE, Litle VR.

J Thorac Cardiovasc Surg. 2008 Feb;135(2):255-60; discussion 260. doi: 10.1016/j.jtcvs.2007.08.055. Epub 2007 Dec 26.

3.

Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.

Slaby O, Srovnal J, Radova L, Gregar J, Juracek J, Luzna P, Svoboda M, Hajduch M, Ehrmann J.

Carcinogenesis. 2015 May;36(5):521-7. doi: 10.1093/carcin/bgv023. Epub 2015 Mar 16.

PMID:
25784377
4.

MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.

Wu X, Ajani JA, Gu J, Chang DW, Tan W, Hildebrandt MA, Huang M, Wang KK, Hawk E.

Cancer Prev Res (Phila). 2013 Mar;6(3):196-205. doi: 10.1158/1940-6207.CAPR-12-0276.

5.

MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.

Yang H, Gu J, Wang KK, Zhang W, Xing J, Chen Z, Ajani JA, Wu X.

Clin Cancer Res. 2009 Sep 15;15(18):5744-52. doi: 10.1158/1078-0432.CCR-09-0385. Epub 2009 Sep 8.

6.

Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma.

Nguyen GH, Schetter AJ, Chou DB, Bowman ED, Zhao R, Hawkes JE, Mathé EA, Kumamoto K, Zhao Y, Budhu A, Hagiwara N, Wang XW, Miyashita M, Casson AG, Harris CC.

Clin Cancer Res. 2010 Dec 1;16(23):5824-34. doi: 10.1158/1078-0432.CCR-10-1110. Epub 2010 Oct 14.

7.

The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis.

Leidner RS, Ravi L, Leahy P, Chen Y, Bednarchik B, Streppel M, Canto M, Wang JS, Maitra A, Willis J, Markowitz SD, Barnholtz-Sloan J, Adams MD, Chak A, Guda K.

Genes Chromosomes Cancer. 2012 May;51(5):473-9. doi: 10.1002/gcc.21934. Epub 2012 Feb 3.

8.

microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma.

Zhao Y, Schetter AJ, Yang GB, Nguyen G, Mathé EA, Li P, Cai H, Yu L, Liu F, Hang D, Yang H, Wang XW, Ke Y, Harris CC.

Int J Cancer. 2013 Jun 15;132(12):2901-9. doi: 10.1002/ijc.27954. Epub 2012 Dec 17.

9.

MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1.

Streppel MM, Pai S, Campbell NR, Hu C, Yabuuchi S, Canto MI, Wang JS, Montgomery EA, Maitra A.

Clin Cancer Res. 2013 Aug 1;19(15):4067-78. doi: 10.1158/1078-0432.CCR-13-0601. Epub 2013 Jun 11.

10.

MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.

Drahos J, Schwameis K, Orzolek LD, Hao H, Birner P, Taylor PR, Pfeiffer RM, Schoppmann SF, Cook MB.

Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):429-37. doi: 10.1158/1055-9965.EPI-15-0161. Epub 2015 Nov 24.

11.

MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma.

Wijnhoven BP, Hussey DJ, Watson DI, Tsykin A, Smith CM, Michael MZ; South Australian Oesophageal Research Group.

Br J Surg. 2010 Jun;97(6):853-61. doi: 10.1002/bjs.7000.

PMID:
20301167
12.

Deciphering the unique microRNA signature in human esophageal adenocarcinoma.

Saad R, Chen Z, Zhu S, Jia P, Zhao Z, Washington MK, Belkhiri A, El-Rifai W.

PLoS One. 2013 May 28;8(5):e64463. doi: 10.1371/journal.pone.0064463. Print 2013.

13.

MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.

Lin RJ, Xiao DW, Liao LD, Chen T, Xie ZF, Huang WZ, Wang WS, Jiang TF, Wu BL, Li EM, Xu LY.

J Surg Oncol. 2012 Feb;105(2):175-82. doi: 10.1002/jso.22066. Epub 2011 Aug 22.

PMID:
21882196
14.

Research on the typical miRNA and target genes in squamous cell carcinoma and adenocarcinoma of esophagus cancer with DNA microarray.

Wang HB, Jiang ZB, Li M.

Pathol Oncol Res. 2014 Apr;20(2):245-52. doi: 10.1007/s12253-013-9688-z. Epub 2014 Feb 12.

PMID:
24519530
15.

Salivary microRNAs as promising biomarkers for detection of esophageal cancer.

Xie Z, Chen G, Zhang X, Li D, Huang J, Yang C, Zhang P, Qin Y, Duan Y, Gong B, Li Z.

PLoS One. 2013;8(4):e57502. doi: 10.1371/journal.pone.0057502. Epub 2013 Apr 1.

16.

Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma.

Nancarrow DJ, Clouston AD, Smithers BM, Gotley DC, Drew PA, Watson DI, Tyagi S, Hayward NK, Whiteman DC; Australian Cancer Study; Study of Digestive Health.

PLoS One. 2011;6(7):e22513. doi: 10.1371/journal.pone.0022513. Epub 2011 Jul 28.

17.

Hypoxia-regulated MicroRNAs in Gastroesophageal Cancer.

Winther M, Alsner J, Sørensen BS, Wittrup CF, Tramm T, Baeksgaard L, Hofland K, Holtved E, Nordsmark M.

Anticancer Res. 2016 Feb;36(2):721-30.

PMID:
26851030
18.

A review of the current understanding and clinical utility of miRNAs in esophageal cancer.

Sakai NS, Samia-Aly E, Barbera M, Fitzgerald RC.

Semin Cancer Biol. 2013 Dec;23(6 Pt B):512-21. doi: 10.1016/j.semcancer.2013.08.005. Epub 2013 Sep 3. Review.

PMID:
24013023
19.

Prognostic significance of differentially expressed miRNAs in esophageal cancer.

Hu Y, Correa AM, Hoque A, Guan B, Ye F, Huang J, Swisher SG, Wu TT, Ajani JA, Xu XC.

Int J Cancer. 2011 Jan 1;128(1):132-43. doi: 10.1002/ijc.25330.

20.

miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes.

Zhang YK, Zhu WY, He JY, Chen DD, Huang YY, Le HB, Liu XG.

J Cancer Res Clin Oncol. 2012 Oct;138(10):1641-50. Epub 2012 May 22.

PMID:
22618509

Supplemental Content

Support Center